# OnCo record adaura (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/adaura/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "adaura", "NCT02511106" ;
  schema:name "ADAURA"@en ;
  schema:alternateName "Adjuvant osimertinib after complete resection of EGFR-mutant lung cancer"@en, "ADAURA trial"@en ;
  schema:description "Showed a targeted pill after lung cancer surgery halves the risk of death, the first such result for a targeted therapy."@en ;
  schema:url <https://onco.cc/trials/adaura/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02511106>, <https://doi.org/10.1016/j.jtho.2026.104179>, <https://www.nice.org.uk/guidance/ta1043> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2015-10-21" ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/egfr-mutant-nsclc/>, <https://onco.cc/cancers/resectable-nsclc/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:targets <https://onco.cc/targets/egfr/> ;
  onco:drugs <https://onco.cc/drugs/osimertinib/> ;
  onco:companies <https://onco.cc/companies/ctong/> ;
  onco:trials <https://onco.cc/trials/alina/>, <https://onco.cc/trials/keynote-091/>, <https://onco.cc/trials/nct02486718/>, <https://onco.cc/trials/ialt/>, <https://onco.cc/trials/lace-pooled-analysis/> ;
  onco:people <https://onco.cc/people/roy-herbst/>, <https://onco.cc/people/wu-yi-long/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-flaura-nejm-2018/>, <https://onco.cc/key-papers/paper-adaura-8-year-os-jto-2026/> .